Insomnia and the increased use of sleeping pills among the elderly: Problems and alternative therapy;Insomnie et utilisation accrue de somnifères chez les aînés: Problématique et alternative de traitement

Canadian Family Physician

Volumn 52, Issue 8, 2006, Pages 968-973

  Bélanger, Lynda ^a   Vallières, Annie ^a   Morin, Charles M ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; LORAZEPAM;

AGING; ALTERNATIVE MEDICINE; BEHAVIOR THERAPY; CLINICAL FEATURE; COGNITIVE THERAPY; DRUG EFFICACY; HUMAN; INFORMATION RETRIEVAL; INSOMNIA; MEDLINE; MENTAL HEALTH; PHYSICAL EXAMINATION; POLYSOMNOGRAPHY; PREVALENCE; PSYCINFO; REVIEW; SCREENING TEST; SLEEP APNEA SYNDROME; SLEEP DISORDER; UNSPECIFIED SIDE EFFECT;

AGED; COGNITIVE THERAPY; COMPLEMENTARY THERAPIES; DRUG INTERACTIONS; HUMANS; HYPNOTICS AND SEDATIVES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 33749024204     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Morgan K, Clarke D. Risk factors for late-life insomnia in a representative general practice sample. Br J Gen Pract 1997;47:166-9.
2. Morgan K, Clarke D. Longitudinal trends in late-life insomnia: implications for prescribing. Age Ageing 1997;26:179-84.
3. Foley DJ, Monjan A, Simonsick EM, Wallace RB, Blazer DG. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6800 persons over three years. Sleep 1999;22(Suppl 2):S366-72.
4. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111.
5. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA 1989;262:1479-84.
6. Cricco M, Simonsick EM, Foley DJ. The impact of insomnia on cognitive functioning in older adults. J Am Geriatr Soc 2001;49:1185-9.
7. Léger D, Guilleminault C, Bader G, Levy E, Paillard M. Medical and socio-professional impact of insomnia. Sleep 2002;25:625-9.
8. Léger D. Insomnia and quality of life. Insomnia 2003;1:29-31.
9. Ohayon M, Caulet M, Lemoine P. Sujets âgés, habitudes de sommeil et consommation de psychotropes dans la population française. Encéphale 1996;22:337-50.
10. Tamblyn R, Abrahamovicz M, duBerger R, McLeod P, Bartlett G. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc 2005;53:233-41.
11. Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long term benzodiazepine use: a meta-analysis. CNS Drugs 2004;18:37-48.
12. Lichstein KL, Morin CM. Treatment of late-life insomnia. Thousand Oaks, Calif: Sage Publications; 2000.
13. Baillargeon L, Demers M, Ladouceur R. Stimulus-control: nonpharmacologic treatment for insomnia. Can Fam Physician 1998;44:73-9.
14. Bliwise DL. Sleep in normal aging and dementia. Sleep 1993;16:40-81.
15. Morin CM, Gramling SE. Sleep patterns and aging: comparison of older adults with and without insomnia complaints. Psychol Aging 1989;4:290-4.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed (text revision). Washington, DC: American Psychiatric Association; 2000.
17. Foley DJ, Monjan A, Brown L, Simonsick EM, Wallace RB, Blazer DG. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995;18:425-32.
18. Quan SF, Katz R, Olson J, Bonekat W, Enright PL, Young T et al. Factors associated with incidence and persistence of symptoms of disturbed sleep in an elderly cohort: the cardiovascular health study. Am J Med Sci 2005;329:163-72.
19. Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults. Results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004;56:497-502.
20. Bliwise NG, Bliwise DL, Dement WC. Age and psychopathology in insomnia. Clin Gerontol 1985;4:3-9.
21. Morin CM, Stone J, Trinkle D, Mercer J, Remsberg S. Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia complaints. Psychol Aging 1993;8:463-7.
22. National Institutes of Health. Consensus development conference statement: the treatment of sleep disorders of older people. Sleep 1991;14:169-77.
23. Guay B, Morin CM. Comment évaluer un problème d'insomnie? Méd Qué 2002;37:97-109.
24. Sateia MJ, Doghramji K, Hauri PJ, Morin CM. Evaluation of chronic insomnia. Sleep 2000;23:243-308.
25. Littner M, Hirshkowitz M, Kramer M, Kapen S, Anderson WM, Bailey D, et al. Practice parameters for using polysomnography to evaluate insomnia: an update. Sleep 2003;26:754-60.
26. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry 1985;42:225-32.
27. Ohayon M, Caulet M. Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry 1996;41:457-64.
28. Hohagen F, Kappler C, Schranom E, Weyerrer S, Riemann D, Berger M. Prevalence of insomnia in elderly general practice attenders and the current treatment modalities. Acta Psychiatr Scand 1994;90:102-8.
29. Simon GE, VonKorff M, Barlow W, Pabiniak C, Wagner E. Predictors of benzodiazepine use in a health maintenance organization sample. J Clin Epidemiol 1996;49:1067-73.
30. Iliffe S, Curran HV, Collins R, Yuen Kee C, Fletcher S, Woods B. Attitude to long-term use of benzodiazepine hypnotics by older people in general practice: findings from interviews with service users and providers. Aging Ment Health 2004;8:242-8.
31. Bastien CH, LeBlanc M, Carrier J, Morin CM. Sleep EEG power spectra, insomnia and chronic use of benzodiazepines. Sleep 2003;26:313-7.
32. Soldatos CR, Dikeos DG, Whitehead A. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. Int Clin Psychopharmacol 1999;14:287-303.
33. Tamblyn RM, McLeod PJ, Abrahamovitz M, Monette J, Gayton DC, Berkson L, et al. Questionable prescribing for elderly patients in Quebec. CMAJ 1994;150:1801-9.
34. Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987;316:363-9.
35. Barre E, Bisseux L, Chiadmi F, Toledano A, Cisternino S, Schlatter J, et al. Drug interactions in an elderly population. Prospective assessment of their frequency and seriousness among 56 patients. Presse Med 2005;34:837-41.
36. Van der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, van der Cammen TJ, Stricker BH, et al. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria - a population-based cohort study. Br J Clin Pharmacol 2005;60:137-44.
37. Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003;17:825-37.
38. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 1999;47:40-50.
39. Ray WA, Fought RL, Decker MD. Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 1992;13:873-83.
40. Avidan AY, Fries BE, James ML, Szafara KL, Wright GT, Chervin RD. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc 2005;53:955-62.
41. Baillargeon L, Landreville P, Verreault R, Beauchemin J-P, Grégoire J-P, Morin CM. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioral therapy combined with gradual tapering: a randomized trial. CMAJ 2003;169:1015-20.
42. Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, Vallières A. Randomized clinical trial of supervised tapering and cognitive-behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry 2004;161:332-42.
43. Bélanger L, Morin CM, Bastien CH, Ladouceur R. Relationships between self-efficacy and compliance with benzodiazepine taper in older adults with chronic insomnia. Health Psychol 2005;24:281-7.
44. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994;151:1172-80.
45. Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol 1995;63:79-89.
46. Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002;159:5-11.
47. Morin CM, Hauri PJ, Espie CA, Spielman A, Buysse DJ, Bootzin RR. Nonpharmacologic treatment of chronic insomnia. Sleep 1999;22:1-25.
48. Morin CM, Espie C. Insomnia: a clinical guide to assessment and treatment. New York, NY: Kluwer Academic/Plenum Publishers; 2003.
49. Morin CM. Vaincre les ennemis du sommeil. Montréal, Qué: Les Éditions de l'Homme; 1997.
50. Wiebe E, Greiver M. Using cognitive behavioural therapy in practice. Qualitative study of family physicians' experiences. Can Fam Physician 2005;51:992-3. Accessible à: www.cfpc.ca/cfp/2005/Jul/vol51_jul-research- 2.asp. Accédé le 29 juin 2006.
51. Chilcott LA, Shapiro CM. The socioeconomic impact of insomnia: an overview. Pharmacoeconomics 1996;10(Suppl 1):S1-14.
52. Simon G, VonKorff M. Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 1997;154:1417-23.